Biotech lands Latin Amer­i­can gov’t di­a­betes con­tract

Di­ag­nos awarded $4.16M (U.S.) project with Mex­ico

Stockwatch Daily - - FRONT PAGE - Mr. An­dre Lar­ente re­ports

DI­AG­NOS INC. has signed a new con­tract val­ued at $4.16-mil­lion (U.S.). This con­tract was awarded af­ter the com­ple­tion of a suc­cess­ful pi­lot pro­gram cover­ing 79,407 pa­tients.

“Based on the ex­e­cu­tion and re­sults from our 2016 pi­lot pro­gram, ISSSTE (In­sti­tuto de Se­guri­dad y Ser­vi­cios So­ciales de los Traba­jadores del Es­tado) now has en­trusted Di­ag­nos to screen, man­age and mon­i­tor up to 320,000 pa­tients for the re­main­ing of 2017. Of these pa­tients, all of the 79,407 un-

der Di­ag­nos care, ex­ist­ing pa­tients from 2016 will be re­screened in 2017,” said An­dre Lar­ente, pres­i­dent of Di­ag­nos. “Af­ter two years of de­ploy­ing screen­ing projects in­ter­na­tion­ally in more than 15 coun­tries, Di­ag­nos is highly com­mit­ted to add value to more health pro­grams by pro­vid­ing state-of-the-art tech­nol­ogy ac­ces­si­ble to peo­ple around the world at very com­pet­i­tive cost. Our FLAIRE AI (ar­ti­fi­cial in­tel­li­gence) tech­nol­ogy plat­form will be ex­panded this year to new patholo­gies dis­cov­er­ies that will ben­e­fit the di­a­betic pop­u­la­tion and oth­ers.”

“Our ap­proach is to mon­i­tor ISSSTE’s di­a­betic pop­u­la­tion over a three-year pe­riod. Pa­tients screened this year will be back for year 2 and year 3 screen­ings. This re­cur­ring rev­enue for Di­ag­nos en­sures the sus­tain­abil­ity of our ser­vices for the fu­ture. Di­ag­nos runs and man­ages the cen­tred pa­tient ori­ented pro­grams known for the MIDE di­a­betes pro­gram of ISSSTE,” said Guillermo Moreno, vice-pres­i­dent of Di­ag­nos.

“At ISSSTE we are com­mit­ted to pro­vide medi­care and so­cial se­cu­rity to all of our 13 mil­lion af­fil­i­ates with the best-of-breed tech­nol­ogy and innovative health ser­vices avail­able world­wide. In a strate­gic part­ner­ship, ISSSTE and Di­ag­nos will con­tinue to work closely to mon­i­tor our pa­tients and de­velop new innovative health so­lu­tions,” said Jose Reyes Baeza, di­rec­tor gen­eral of ISSSTE.

About About Di­ag­nos Inc.

Di­ag­nos Cana­dian cor­po­ra­tion with a mis­sion to com­mer­cial­ize tech­nolo­gies com­bin­ing con­tex­tual imag­ing, text and tra­di­tional data min­ing. Di­ag­nos has de­vel­oped its own ar­ti­fi­cial in­tel­li­gence (AI) tech­nolo­gies, CARA and FLAIRE.

We seek Safe Har­bor.

Ne­tan Choudhry, Ge­orges Lawrence He­bert, M An­dre Lar­ente, P Philip Re­naud, Lloyd Mitchell Se­gal, Michael Singer

(ADK) Shares: 165,727,727

Newspapers in English

Newspapers from Canada

© PressReader. All rights reserved.